Reimbursement

Dr. Ronald Hirsch of R1 RCM discusses new Alzheimer’s drug Leqembi with HFMA’s Nick Hut

Erika Grotto
August 2, 2023 9:48 am

Dr. Ronald Hirsch of R1 RCM discusses considerations around a new Alzheimer’s drug with Senior Editor Nick Hut.

Mentioned in this episode:

CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS

NCA – Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) – Proposed Decision Memo (cms.gov)

About the Author

Erika Grotto

is a senior editor at HFMA and is based in Downers Grove, Ill.
See All Articles

Related Tags

Advertisements

googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text1' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text2' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text3' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text4' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text5' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text6' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-text7' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-cube1' ); } );
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-cube2' ); } );

Recent Reimbursement

Which healthcare policies were kept in a doomed second version of the continuing resolution?

Year-end spending legislation looks promising for healthcare stakeholders — if it passes

CY 2025 OPPS/ASC Final Rule Summary

googletag.cmd.push( function () { googletag.display( 'hfma-gpt-cube3' ); } );
Recommended Articles